|
Multiple sclerosis
Citations 21-30 of 469 total displayed.
|
Past content
(since Jan 2001):
|
- EDITORIALS
Transcranial sonography of deep gray nuclei: A new outcome measure in multiple sclerosis?
- Istvan Pirko and Robert Zivadinov
Neurology 2009; 73: 1006-1007.
[Full text]
[PDF]
- ARTICLES
Transcranial brain sonography findings predict disease progression in multiple sclerosis
- U. Walter, S. Wagner, S. Horowski, R. Benecke, and U. K. Zettl
Neurology 2009; 73: 1010-1017.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy
- A. van der Walt, J. Stankovich, M. Bahlo, B. V. Taylor, I.A.F. van der Mei, S. J. Foote, T. J. Kilpatrick, J. P. Rubio, and H. Butzkueven
Neurology 2009; 73: 1018-1025.
[Abstract]
[Full text]
[PDF]
- EDITORIALS
Iatrogenic immunosuppression with biologics in MS. Expecting the unexpected?
- Olaf Stüve and Heinz Wiendl
Neurology first published on September 23, 2009 as doi: WNL.0b013e3181beed38.
Rapid PDF
- CLINICAL/SCIENTIFIC NOTES
Ocular toxoplasmosis during natalizumab treatment
- Chiara Zecca, Fabio Nessi, Enos Bernasconi, and Claudio Gobbi
Neurology first published on September 23, 2009 as doi: WNL.0b013e3181bd114f.
Rapid PDF
- EDITORIALS
What you see depends on how you look: Gray matter lesions in multiple sclerosis
- Declan T. Chard and David H. Miller
Neurology 2009; 73: 918-919.
[Full text]
[PDF]
- ARTICLES
In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI
- C. Mainero, T. Benner, A. Radding, A. van der Kouwe, R. Jensen, B. R. Rosen, and R. P. Kinkel
Neurology 2009; 73: 941-948.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Plasma exchange for acute attacks of CNS demyelination: Predictors of improvement at 6 months
- S. Llufriu, J. Castillo, Y. Blanco, L. Ramió-Torrentà, J. Río, M. Vallès, M. Lozano, M. D. Castellà, J. Calabia, A. Horga, F. Graus, X. Montalban, and A. Saiz
Neurology 2009; 73: 949-953.
[Abstract]
[Full text]
[PDF]
- VIEWS AND REVIEWS
The present efficacy of multiple sclerosis therapeutics: Is the new 66% just the old 33%?
- Eric C. Klawiter, Anne H. Cross, and Robert T. Naismith
Neurology 2009; 73: 984-990.
[Abstract]
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
SEVERE CARDIAC FAILURE IN A PATIENT WITH MULTIPLE SCLEROSIS FOLLOWING LOW-DOSE MITOXANTRONE TREATMENT
- J. Dörr, A. Bitsch, K.J.G. Schmailzl, A. Chan, N. von Ahsen, M. Hummel, R. Varon, C. M. Lill, H. -P. Vogel, F. Zipp, and F. Paul
Neurology 2009; 73: 991-993.
[Full text]
[PDF]
|
|
